On December 30, VGH announced it had ‘received a number of non-binding, conditional offers to acquire the company. These offers value the Company appreciably above the current share price…’
The company also said its core business and cash flow remains strong and that it continues to make good progress in doctor partner contract re-negotiations.
VGH Price at posting:
59.5¢ Sentiment: LT Buy Disclosure: Held
